Abstract
Renal cell carcinoma (RCC) is a common urological malignant carcinoma, also the most popular subtype of renal tumors. In the early stage of RCC, patients always have less clinical symptoms, which leads to the poor prognosis. Renal carcinogenesis is involved in the cytogenetic and molecular alterations. What's more, the understanding of RCC was improved since the development and the application of the molecular biology and genomics experimental technique, including the pathogenesis and etiology, targeted therapeutic strategies and prognostic factors of RCC. The goal of this review is to overview the research advances of renal tumors. Key words: Renal cell carcinoma; Therapeutic strategy
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
